Life Science
Cadent Ltd. ('Computer Aided Dentistry') provides web-based 3D digital models and related products to the dental industry, thus overcoming all the constraints attached to physical plaster models (i.e., limited diagnostic value, cumbersome production techniques and costly storage fees). Cadent's product, OrthoCad, is a solution for generating and distributing digital 3D models for orthodontics. In the field of Crown & Bridge, Cadent is presently developing the EID (Electronic Impression Device), a pen-like 3D scanner to enable impression-free acquisition of the relevant intra-oral topology.
Glycominds Ltd. is focused on the commercialization of proprietary biomarkers for autoimmune diseases, the largest unmeet need tests market. Glycominds Ltd. is pioneering the application of glycomics science to clinical practice, in order to significantly improve the quality of treatment decisions for patients with autoimmune diseases.The company's pipeline includes tests for other autoimmune diseases - which are among the most recognized and poorly understood illnesses. Glycominds's initial products are based on their newly discovered biomarkers for Multiple Sclerosis (MS) - currently in the validation phase of product development in the course of the PRACTIMS and DECISION study and Crohn's Disease (CD). The company's series for GI test, the IBDX™ product line, will soon be launched to the European market.
A merger between IDEAS and Gamma Medica
FIF invested in IDEAS, a unique expertise lies in the area of radiation detection and imaging technology. IDEAS develops and supplies high-technology products for use within nuclear medicine, security and safety, medical x-ray, biomedicine, industrial inspection and physics. Ideas represents a world-class center for research and commercial development of solid-state camera heads and detection modules which provide high quality and high-resolution digital images. The company delivers standard products which utilize semiconductor sensors combined with advanced readout electronics, as well as customized solutions.
Gamma Medica designs, develops, and manufactures next-generation imaging systems for both clinical and pre-clinical applications.
Real-Time Radiography is a world leader in designing and manufacturing of flat-panel X-ray detectors based on its proprietary Mercuric Iodide coating and advanced CMOS readout circuitry technology. The synergy of innovative mercuric iodide deposition technologies combined with very high-speed, low-level precise readout electronics provides for sophisticated yet economical solutions for digital detectors used in general radiography, mammography, fluoroscopy, gastro-intestinal, angiography and cardiac applications. Real-Time Radiography detectors enable data acquisition at up to 120 frames per second, delivering image quality with edge-to-edge clarity, dose efficiency and clinical performance across the full range of imaging applications.
A new development (in progress) of an X-Ray sensor for the dental use.
Sightline Technologies Ltd is a medical device company engaged in developing, manufacturing and marketing advanced endoscopic solutions for gastro-enterological applications. SightLine's primary focus is to develop and market patented video endoscopic systems for imaging diagnostics and therapy and to improve the overall quality of healthcare by bringing new insight to the world of gastroscopy. In a field where little has changed since its inception, Sightline has created new technologies that enhance the physician's ease of use, cost productivity, safety and patient comfort. SightLine is currently concentrating its attention on three product families: a video robot for the early detection and treatment of cancer of the colon; a fingertip-mounted video camera that will serve as a platform for a wide range of procedures in proctology, gynecology, plastic surgery, emergency medicine, and general surgery; and a disposable rigid video sigmoidoscope.
